RecruitingNCT03233087

Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study

Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen


Sponsor

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Enrollment

1,500 participants

Start Date

Mar 1, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria4

  • Retrospective
  • All patients who were referred to the surgical service for evaluation and management of aortic dissection were included.
  • Perspective
  • Patients with initial suspicion of having AAD were perspectively enrolled.

Exclusion Criteria8

  • Retrospective
  • Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken;
  • Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer;
  • Patients who entered the hospital for checkups after surgery.
  • Perspective
  • Patients in whom there is little or no suspicion of a life-threatening disease;
  • Patients with confirmed acute myocardial infarction,angina or pulmonary embolism
  • The symptoms were clearly not related to AD (e.g. pleurisy, pneumonia, acute abdominal diseases).

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Beijing Anzhen Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03233087


Related Trials